Hemophagocytosis causes a consumptive anemia of inflammation

Journal of Experimental Medicine

Volumn 208, Issue 6, 2011, Pages 1203-1214

  Zoller, Erin E ^a   Lykens, Jennifer E ^a   Terrell, Catherine E ^a   Aliberti, Julio ^a   Filipovich, Alexandra H ^a   Henson, Peter M ^b   Jordan, Michael B ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

^b DEPARTMENT OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOPENIA; ENDOCYTOSIS; ERYTHROPHAGOCYTOSIS; IN VIVO STUDY; INTERFERON PRODUCTION; LYMPHOCYTIC CHORIOMENINGITIS; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANEMIA; ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CELL SEPARATION; CRICETINAE; ENDOCYTOSIS; FLOW CYTOMETRY; INFLAMMATION; INTERFERON-GAMMA; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PHAGOCYTOSIS; SPLEEN;

EID: 79958292813     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20102538     Document Type: Article

References (70)

1. Abshire, T.C. 1996. The anemia of inflammation. A common cause of childhood anemia. Pediatr. Clin. North Am. 43:623-637.
2. Agarwal, N., and J.T. Prchal. 2009. Anemia of chronic disease (anemia of inflammation). Acta Haematol. 122:103-108.
3. Agarwal, S., S. Narayan, S. Sharma, E. Kahkashan, and A.K. Patwari. 2006. Hemophagocytic syndrome associated with visceral leishmaniasis. Indian J. Pediatr. 73:445-446.
4. Alexander, W.R., J. Richmond, L.M. Roy, and J.J. Duthie. 1956. Nature of anaemia in rheumatoid arthritis. II. Survival of transfused erythrocytes in patients with rheumatoid arthritis. Ann. Rheum. Dis. 15:12-20.
5. Amyere, M., M. Mettlen, P. Van Der Smissen, A. Platek, B. Payrastre, A. Veithen, and P.J. Courtoy. 2002. Origin, originality, functions, subversions and molecular signalling of macropinocytosis. Int. J. Med. Microbiol. 291:487- 494.
6. Ando, M., E. Miyazaki, S. Hiroshige, Y. Ashihara, T. Okubo, M. Ueo, T. Fukami, K. Sugisaki, T. Tsuda, K. Ohishi, et al. 2006. Virus associated hemophagocytic syndrome accompanied by acute respiratory failure caused by influenza A (H3N2). Intern. Med. 45:1183-1186.
7. Ballin, A., A. Lotan, F. Serour, A. Ovental, M. Boaz, Y. Senecky, and S. Rief. 2009. Anemia of acute infection in hospitalized children-no evidence of hemolysis. J. Pediatr. Hematol. Oncol. 31:750-752.
8. Bateman, S.T., J. Lacroix, K. Boven, P. Forbes, R. Barton, N.J. Thomas, B. Jacobs, B. Markovitz, B. Goldstein, J.H. Hanson, et al; Pediatric Acute Lung Injury and Sepsis Investigators Network. 2008. Anemia, blood loss, and blood transfusions in North American children in the intensive care unit. Am. J. Respir. Crit. Care Med. 178:26-33.
9. Behrens, E.M., T. Beukelman, M. Paessler, and R.Q. Cron. 2007. Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. J. Rheumatol. 34:1133-1138.
10. Binker, M.G., D.Y. Zhao, S.J. Pang, and R.E. Harrison. 2007. Cytoplasmic linker protein-170 enhances spreading and phagocytosis in activated macrophages by stabilizing microtubules. J. Immunol. 179:3780-3791.
11. Boehm, U., T. Klamp, M. Groot, and J.C. Howard. 1997. Cellular responses to interferon-gamma. Annu. Rev. Immunol. 15:749-795.
12. Brown, T.D., P.J. Goodman, T. Fleming, J.S. Macdonald, T. O'Rourke, S.A. Taylor, J.R. Neefe, and E. Gaynor. 1991. Phase II trial of recombinant DNA gamma-interferon in advanced colorectal cancer: a Southwest Oncology Group study. J. Immunother. 10:379-382.
13. Cassatella, M.A., L. Hartman, B. Perussia, and G. Trinchieri. 1989. Tumor necrosis factor and immune interferon synergistically induce cytochrome b-245 heavy-chain gene expression and nicotinamide-adenine dinucleotide phosphate hydrogenase oxidase in human leukemic myeloid cells. J. Clin. Invest. 83:1570-1579.
14. Conner, S.D., and S.L. Schmid. 2003. Regulated portals of entry into the cell. Nature. 422:37-44.
15. Corwin, H.L., A. Gettinger, R.G. Pearl, M.P. Fink, M.M. Levy, E. Abraham, N.R. MacIntyre, M.M. Shabot, M.S. Duh, and M.J. Shapiro. 2004. The CRIT Study: anemia and blood transfusion in the critically ill- current clinical practice in the United States. Crit. Care Med. 32:39-52.
16. Deguchi, M., H. Sakuta, K. Uno, K. Inaba, and S. Muramatsu. 1995. Exogenous and endogenous type I interferons inhibit interferon-gamma-induced nitric oxide production and nitric oxide synthase expression in murine peritoneal macrophages. J. Interferon Cytokine Res. 15:977-984.
17. Dror, N., M. Alter-Koltunoff, A. Azriel, N. Amariglio, J. Jacob-Hirsch, S. Zeligson, A. Morgenstern, T. Tamura, H. Hauser, G. Rechavi, et al. 2007. Identification of IRF-8 and IRF-1 target genes in activated macrophages. Mol. Immunol. 44:338-346.
18. Fernandez-Boyanapalli, R., K.A. McPhillips, S.C. Frasch, W.J. Janssen, M.C. Dinauer, D.W. Riches, P.M. Henson, A. Byrne, and D.L. Bratton. 2010. Impaired phagocytosis of apoptotic cells by macrophages in chronic granulomatous disease is reversed by IFN-γ in a nitric oxide-dependent manner. J. Immunol. 185:4030-4041.
19. Filipovich, A.H. 2008. Hemophagocytic lymphohistiocytosis and other hemophagocytic disorders. Immunol. Allergy Clin. North Am. 28:293-313.
20. Fossati-Jimack, L., L. Reininger, Y. Chicheportiche, R. Clynes, J.V. Ravetch, T. Honjo, and S. Izui. 1999. High pathogenic potential of low-affinity autoantibodies in experimental autoimmune hemolytic anemia. J. Exp. Med. 190:1689-1696.
21. Gardai, S.J., K.A. McPhillips, S.C. Frasch, W.J. Janssen, A. Starefeldt, J.E. Murphy-Ullrich, D.L. Bratton, P.A. Oldenborg, M. Michalak, and P.M. Henson. 2005. Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell. 123:321-334.
22. Gardai, S.J., D.L. Bratton, C.A. Ogden, and P.M. Henson. 2006. Recognition ligands on apoptotic cells: a perspective. J. Leukoc. Biol. 79:896-903.
23. Henter, J.I., G. Elinder, O. Söder, M. Hansson, B. Andersson, and U. Andersson. 1991. Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood. 78:2918-2922.
24. Henter, J.I., M. Aricò, G. Elinder, S. Imashuku, and G. Janka. 1998. Familial hemophagocytic lymphohistiocytosis. Primary hemophagocytic lymphohistiocytosis. Hematol. Oncol. Clin. North Am. 12:417-433.
25. Hildeman, D., D. Yañez, K. Pederson, T. Havighurst, and D. Muller. 1997. Vaccination against persistent viral infection exacerbates CD4+ T-cellmediated immunopathological disease. J. Virol. 71:9672-9678.
26. Hinze, C.H., N. Fall, S. Thornton, J.Q. Mo, B.J. Aronow, G. Layh-Schmitt, T.A. Griffin, S.D. Thompson, R.A. Colbert, D.N. Glass, et al. 2010. Immature cell populations and an erythropoiesis gene-expression signature in systemic juvenile idiopathic arthritis: implications for pathogenesis. Arthritis Res. Ther. 12:R123.
27. Hoffmann, P.R., A.M. deCathelineau, C.A. Ogden, Y. Leverrier, D.L. Bratton, D.L. Daleke, A.J. Ridley, V.A. Fadok, and P.M. Henson. 2001. Phosphatidylserine (PS) induces PS receptor-mediated macropinocytosis and promotes clearance of apoptotic cells. J. Cell Biol. 155:649-659.
28. Hsieh, S.M., and S.C. Chang. 2006. Insufficient perforin expression in CD8+ T cells in response to hemagglutinin from avian influenza (H5N1) virus. J. Immunol. 176:4530-4533.
29. Hu, X., and L.B. Ivashkiv. 2009. Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases. Immunity. 31:539-550.
30. Huse, M., B.F. Lillemeier, M.S. Kuhns, D.S. Chen, and M.M. Davis. 2006. T cells use two directionally distinct pathways for cytokine secretion. Nat. Immunol. 7:247-255.
31. Imashuku, S., S. Hibi, F. Fujiwara, S. Ikushima, and S. Todo. 1994. Haemophagocytic lymphohistiocytosis, interferon-gamma-naemia and Epstein-Barr virus involvement. Br. J. Haematol. 88:656-658.
32. Imashuku, S., S. Hibi, Y. Tabata, M. Sako, Y. Sekine, K. Hirayama, H. Sakazaki, N. Maeda, H. Kito, H. Shichino, and H. Mugishima. 1998. Biomarker and morphological characteristics of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis. Med. Pediatr. Oncol. 31:131-137.
33. Imran, M.N., P.H. Leng, S. Yang, A. Kurup, and P. Eng. 2005. Early predictors of mortality in pneumococcal bacteraemia. Ann. Acad. Med. Singapore. 34:426-431.
34. Ino, Y., T. Sato, S. Suzuki, M. Iwaki, and T. Yoshikawa. 1987. Inhibitory effects of FUT-175, a new synthetic protease inhibitor, on intravascular hemolysis by human serum in mice. Int. J. Immunopharmacol. 9:533-537.
35. Ishikawa-Sekigami, T., Y. Kaneko, H. Okazawa, T. Tomizawa, J. Okajo, Y. Saito, C. Okuzawa, M. Sugawara-Yokoo, U. Nishiyama, H. Ohnishi, et al. 2006. SHPS-1 promotes the survival of circulating erythrocytes through inhibition of phagocytosis by splenic macrophages. Blood. 107:341-348.
36. Ito, S., N. Takada, A. Ozasa, M. Hanada, M. Sugiyama, K. Suzuki, Y. Nagae, T. Inagaki, Y. Suzuki, and H. Komatsu. 2006. Secondary hemophagocytic syndrome in a patient with methicillin-sensitive Staphylococcus aureus bacteremia due to severe decubitus ulcer. Intern. Med. 45:303-307.
37. Janka, G.E. 2007. Familial and acquired hemophagocytic lymphohistiocytosis. Eur. J. Pediatr. 166:95-109.
38. Janka, G., and U. zur Stadt. 2005. Familial and acquired hemophagocytic lymphohistiocytosis. Hematology (Am Soc Hematol Educ Program). 2005:82-88.
39. Jordan, M.B., N. van Rooijen, S. Izui, J. Kappler, and P. Marrack. 2003. Liposomal clodronate as a novel agent for treating autoimmune hemolytic anemia in a mouse model. Blood. 101:594-601.
40. Jordan, M.B., D. Hildeman, J. Kappler, and P. Marrack. 2004. An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder. Blood. 104:735-743.
41. Kato, T., M. Kitaura, K. Inaba, Y. Watanabe, Y. Kawade, and S. Muramatsu. 1989. Suppression of macrophage Ia antigen expression by endogenous interferon-alpha/beta. J. Interferon Res. 9:393-405.
42. Kempe, D.S., P.A. Lang, C. Duranton, A. Akel, K.S. Lang, S.M. Huber, T. Wieder, and F. Lang. 2006. Enhanced programmed cell death of irondeficient erythrocytes. FASEB J. 20:368-370.
43. Kuebler, J.P., P.J. Goodman, T.D. Brown, E.D. Crawford, C.L. Reitz, W.A. Knight III, and J.A. Kish. 1990. Phase II study of continuous infusion recombinant gamma interferon in renal carcinoma. A Southwest Oncology Group study. Invest. New Drugs. 8:307-309.
44. Kurzrock, R., J.R. Quesada, M.G. Rosenblum, S.A. Sherwin, and J.U. Gutterman. 1986. Phase I study of i.v. administered recombinant gamma interferon in cancer patients. Cancer Treat. Rep. 70:1357-1364.
45. Lin, A.A., P.K. Tripathi, A. Sholl, M.B. Jordan, and D.A. Hildeman. 2009. Gamma interferon signaling in macrophage lineage cells regulates central nervous system inflammation and chemokine production. J. Virol. 83:8604-8615.
46. Lykens, J.E., C.E. Terrell, E.E. Zoller, S. Divanovic, A. Trompette, C.L. Karp, J. Aliberti, M.J. Flick, and M.B. Jordan. 2010. Mice with a selective impairment of IFN-gamma signaling in macrophage lineage cells demonstrate the critical role of IFN-gamma-activated macrophages for the control of protozoan parasitic infections in vivo. J. Immunol. 184:877-885.
47. Marciano, B.E., R. Wesley, E.S. De Carlo, V.L. Anderson, L.A. Barnhart, D. Darnell, H.L. Malech, J.I. Gallin, and S.M. Holland. 2004. Long-term interferon-gamma therapy for patients with chronic granulomatous disease. Clin. Infect. Dis. 39:692-699.
48. Milner, J.D., T. Orekov, J.M. Ward, L. Cheng, F. Torres-Velez, I. Junttila, G. Sun, M. Buller, S.C. Morris, F.D. Finkelman, and W.E. Paul. 2010. Sustained IL-4 exposure leads to a novel pathway for hemophagocytosis, inflammation, and tissue macrophage accumulation. Blood. 116:2476-2483.
49. Mullarky, I.K., F.M. Szaba, L.W. Kummer, L.B. Wilhelm, M.A. Parent, L.L. Johnson, and S.T. Smiley. 2007. Gamma interferon suppresses erythropoiesis via interleukin-15. Infect. Immun. 75:2630-2633.
50. Napolitano, L.M., S. Kurek, F.A. Luchette, H.L. Corwin, P.S. Barie, S.A. Tisherman, P.C. Hebert, G.L. Anderson, M.R. Bard, W. Bromberg, et al; American College of Critical Care Medicine of the Society of Critical Care Medicine; Eastern Association for the Surgery of Trauma Practice Management Workgroup. 2009. Clinical practice guideline: red blood cell transfusion in adult trauma and critical care. Crit. Care Med. 37:3124-3157.
51. Ogden, C.A., A. deCathelineau, P.R. Hoffmann, D. Bratton, B. Ghebrehiwet, V.A. Fadok, and P.M. Henson. 2001. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J. Exp. Med. 194:781-795.
52. Ohga, S., A. Matsuzaki, M. Nishizaki, T. Nagashima, T. Kai, M. Suda, and K. Ueda. 1993. Inflammatory cytokines in virus-associated hemophagocytic syndrome. Interferon-gamma as a sensitive indicator of disease activity. Am. J. Pediatr. Hematol. Oncol. 15:291-298.
53. Ohno, T., A. Shirasaka, T. Sugiyama, and H. Furukawa. 1996. Hemophagocytic syndrome induced by Plasmodium falciparum malaria infection. Int. J. Hematol. 64:263-266.
54. Oldenborg, P.A., A. Zheleznyak, Y.F. Fang, C.F. Lagenaur, H.D. Gresham, and F.P. Lindberg. 2000. Role of CD47 as a marker of self on red blood cells. Science. 288:2051-2054.
55. Pachlopnik Schmid, J., C.H. Ho, F. Chrétien, J.M. Lefebvre, G. Pivert, M. Kosco-Vilbois, W. Ferlin, F. Geissmann, A. Fischer, and G. de Saint Basile. 2009. Neutralization of IFNgamma defeats haemophagocytosis in LCMV-infected perforin- and Rab27a-deficient mice. EMBO Mol Med. 1:112-124.
56. Parodi, A., S. Davì, A.B. Pringe, A. Pistorio, N. Ruperto, S. Magni-Manzoni, P. Miettunen, B. Bader-Meunier, G. Espada, G. Sterba, et al; Lupus Working Group of the Paediatric Rheumatology European Society. 2009. Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients. Arthritis Rheum. 60:3388-3399.
57. Quesada, J.R., R. Kurzrock, S.A. Sherwin, and J.U. Gutterman. 1987. Phase II studies of recombinant human interferon gamma in metastatic renal cell carcinoma. J. Biol. Response Mod. 6:20-27.
58. Reade, M.C., L. Weissfeld, D.C. Angus, J.A. Kellum, and E.B. Milbrandt. 2010. The prevalence of anemia and its association with 90-day mortality in hospitalized community-acquired pneumonia. BMC Pulm. Med. 10:15.
59. Rivera, S., and T. Ganz. 2009. Animal models of anemia of inflammation. Semin. Hematol. 46:351-357.
60. Rosa, F.M., M.M. Cochet, and M. Fellous. 1986. Interferon and major histocompatibility complex genes: a model to analyse eukaryotic gene regulation? Interferon. 7:47-87.
61. Rutenfranz, I., and H. Kirchner. 1988. Pharmacokinetics of recombinant murine interferon-gamma in mice. J. Interferon Res. 8:573-580.
62. Schaller, E., A.J. Macfarlane, R.A. Rupec, S. Gordon, A.J. McKnight, and K. Pfeffer. 2002. Inactivation of the F4/80 glycoprotein in the mouse germ line. Mol. Cell. Biol. 22:8035-8043.
63. Schroder, K., P.J. Hertzog, T. Ravasi, and D.A. Hume. 2004. Interferongamma: an overview of signals, mechanisms and functions. J. Leukoc. Biol. 75:163-189.
64. Strauss, R., D. Neureiter, B. Westenburger, M. Wehler, T. Kirchner, and E.G. Hahn. 2004. Multifactorial risk analysis of bone marrow histiocytic hyperplasia with hemophagocytosis in critically ill medical patients-a postmortem clinicopathologic analysis. Crit. Care Med. 32:1316-1321.
65. Sumegi, J., M.G. Barnes, S.V. Nestheide, S. Molleran-Lee, J. Villanueva, K. Zhang, K.A. Risma, A.A. Grom, and A.H. Filipovich. 2011. Gene expression profiling of peripheral blood mononuclear cells from children with active hemophagocytic lymphohistiocytosis. Blood. 117:e151-e160.
66. Vandivier, R.W., P.M. Henson, and I.S. Douglas. 2006. Burying the dead: the impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease. Chest. 129:1673-1682.
67. Vincent, J.L., J.F. Baron, K. Reinhart, L. Gattinoni, L. Thijs, A. Webb, A. Meier-Hellmann, G. Nollet, and D. Peres-Bota; ABC (Anemia and Blood Transfusion in Critical Care) Investigators. 2002. Anemia and blood transfusion in critically ill patients. JAMA. 288:1499-1507.
68. Walsh, T.S., and E.E. Saleh. 2006. Anaemia during critical illness. Br. J. Anaesth. 97:278-291.
69. Zoumbos, N.C., J.Y. Djeu, and N.S. Young. 1984. Interferon is the suppressor of hematopoiesis generated by stimulated lymphocytes in vitro. J. Immunol. 133:769-774.
70. Zvulunov, A., H. Tamary, and N. Gal. 2002. Pancytopenia resulting from hemophagocytosis in malaria. Pediatr. Infect. Dis. J. 21:1086-1087.